SciELO - Scientific Electronic Library Online

vol.14 issue3Actualización de diagnóstico y tratamiento de la insuficiencia cardíaca de etiología chagásica author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Insuficiencia cardíaca

On-line version ISSN 1852-3862


BARISANI, José Luis. Manejo de la frecuencia cardíaca en la insuficiencia cardíaca . Insuf. card. [online]. 2019, vol.14, n.3, pp.88-95. ISSN 1852-3862.

The association between increased heart rate (HR) and cardiovascular events is well known for the general population, as for all heart diseases. In heart failure with reduced ejection fraction and sinus rhythm, HR is a modifiable risk factor. Its reduction to values that have been shown to improve prognosis should be a therapeutic objective. We discuss what the optimal HR value should be in patients with chronic heart failure and in the vulnerable phase of the hospitalized patient for acute heart failure. The synergism between beta-blockers and ivabradine can be a useful therapeutic option in these cases. In patients with atrial fibrillation, however, there is no conclusive evidence demonstrating evolutionary changes with the HR control.

Keywords : Heart failure; Heart rate; Beta-blockers; Ivabradine; Vulnerable phase; Atrial fibrillation.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License